Conexiant’s news site is now MDSpire News. Learn more
Advertisement
AI Scribes Lag Clinicians on Note Quality
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
Clinical Report: AI Scribes Lag Clinicians on Note Quality
Overview
A study evaluating AI scribe tools found that notes generated by these tools received lower quality scores compared to those written by clinicians across five standardized primary care scenarios. The findings highlight significant gaps in documentation quality, particularly in thoroughness and organization.
Background
The rapid adoption of ambient AI scribes in clinical settings aims to alleviate documentation burdens and improve efficiency. However, the quality of notes produced by these tools has not been thoroughly evaluated, raising concerns about their impact on clinical documentation and patient care. Understanding the limitations of AI-generated notes is crucial for ensuring effective integration into healthcare workflows.
AI-generated notes scored lower than human-generated notes in all 10 quality domains assessed.
The largest deficits in AI notes were in thoroughness, organization, and usefulness.
Statistically significant differences were observed in three out of five scenarios evaluated.
Human notes averaged 43.8 points in the acute low back pain scenario, while AI notes averaged 20.3 points.
Differences in freedom from hallucination and bias were also statistically significant.
Clinical Implications
Clinicians should be aware of the limitations of AI-generated notes, particularly in terms of quality and thoroughness. As AI scribes become more integrated into clinical workflows, ongoing evaluation and oversight will be essential to ensure that documentation meets the necessary standards for patient care.
Conclusion
The findings underscore the need for careful consideration of AI scribe tools in clinical practice, emphasizing the importance of documentation quality alongside efficiency gains.
In a planned BALANCE analysis, elevated day 7 procalcitonin was associated with higher mortality, but the small subgroup analysis found no evidence that extending antibiotics from 7 to 14 days improved outcomes.
Researchers analyzed UK Biobank data to determine whether spending sedentary time in prolonged vs interrupted bouts was associated with subsequent cancer incidence and cancer mortality.
An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.